Clinical Trials Market: By Clinical Trial Phase, By Disease Type, By Design, By End-user and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Clinical Trials Market Size, Share, Growth, Trends, and Global Industry Analysis: By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Disease Type (Infectious diseases, Cancer, Diabetes, Autoimmune disorders, Inflammatory diseases, Cardiovascular diseases, Haematological disorders, Neurological disorders, Dermatology, Others), By Design (Observational trials, Interventional trials, Expanded access trials), By End-user (Clinical research organizations, Pharmaceutical and biotechnology companies, Research institutes, Others) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Clinical Trials Market size was valued at US$ 46.8 billion in the year 2023 and is anticipated to grow US$ 70.23 billion by 2030 at a CAGR of 7.5% from 2024-2030. Clinical trials are research studies primarily performed on humans to get data about the safety and efficacy of newer biomedical interventions including novel devices, vaccines, drugs, and treatments. Generally, clinical trials are regulated by the ethics committees and health authorities. On the broad base, clinical trials are carried out to determine the overall pharmacokinetic and pharmacodynamic properties of the products. Clinical trials are carried out under various phases such as Phase 0 to Phase 3 and Phase 4 is carried out for a post-marketing study of the products.

The product will be recalled if it fails at any stage of the clinical trial. Geographically, the market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. for the development of capabilities in infectious diseases and vaccines. Clinical trials are research investigations in which people volunteer to test medical equipment or pharmaceuticals to figure out how to cure particular diseases or problems. They are carried out to diagnose, detect, and prevent certain diseases. To carry out the testing method, each clinical trial has its own set of protocols and action plans. Clinical trials are used to gather information about the efficacy, safety, and efficacy of pharmaceuticals and medical treatments on animals and humans.

Clinical Trials Market Key Developments

  • In June 2017, Audax private equity acquired the Altasciences Clinical Researches for organizing the clinical trials.
  • In September 2016, Icon Plc has acquired Clinical Research Management, Inc

summary download arrow Download Free Sample

Global Clinical Trials Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.5%

Largest Market

North America

Fastest Growing Market

Europe

Clinical Trials Market Dynamics

Increase in the prevalence of chronic diseases and entry of newer diseases might propel the innovation of novel drugs leads to bolster the market. Acquisitions & mergers, collaborations, and joint ventures between the pharmaceutical and biotechnology companies with clinical research organizations are helping to drive the revenue growth of clinical trials market. For instance, in September 2015, Chiltern acquired the theorem clinical for strengthening the facilities for clinical trials. Similarly, in June 2017, ProPharma group acquired the Drug Safety Solutions for the development of clinical trial facilities. market is in the developed stage owing increase in the R&D activities and innovation of newer biological products and medical devices in the market.

Global Clinical Trials Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2030

US$ 70.23 billion

Market CAGR

7.5%

By Trial Phase

  • Phase 0
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Disease Type

  • Infectious diseases
  • Cancer
  • Diabetes
  • Autoimmune disorders
  • Inflammatory diseases
  • Cardiovascular diseases
  • Haematological disorders
  • Neurological disorders
  • Dermatology
  • Others

By Study Design

  • Observational trials
  • Interventional trials
  • Expanded access trials

By End User

  • Clinical research organizations
  • Pharmaceutical and biotechnology companies
  • Research institutes
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The clinical trials market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global clinical trials market size was valued at US$ 46.8 billion in 2023 and is projected to grow at a CAGR of 7.5% from 2024 to 2030.

The market key players are: Charles River Laboratories International Kendle International Parexel International Corporation Chiltern International Ltd Omnicare Healthcare Co. Audax Group Laboratory Corporation of America Holdings

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Clinical Trials Market Introduction 
2.1.Global Clinical Trials Market  - Taxonomy
2.2.Global Clinical Trials Market  - Definitions
2.2.1.Trial Phase
2.2.2.Disease Type
2.2.3.Study Design
2.2.4.End Users
2.2.5.Region
3. Global Clinical Trials Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Clinical Trials Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Clinical Trials Market  By Trial Phase, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Phase 0
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Phase 1
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Phase 2
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Phase 3
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Phase 4
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Clinical Trials Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Infectious diseases
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cancer
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Diabetes
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Autoimmune disorders
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Inflammatory diseases
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Cardiovascular diseases
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Haematological disorders
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Neurological disorders
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Dermatology
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
6.10. Others
6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.10.3. Market Opportunity Analysis 
7. Global Clinical Trials Market  By Study Design, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Observational trials
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Interventional trials
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Expanded access trials
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Clinical Trials Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Clinical research organizations
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Pharmaceutical and biotechnology companies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research institutes
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Clinical Trials Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Trial Phase Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Phase 0
10.1.2.Phase 1
10.1.3.Phase 2
10.1.4.Phase 3
10.1.5.Phase 4
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Infectious diseases
10.2.2.Cancer
10.2.3.Diabetes
10.2.4.Autoimmune disorders
10.2.5.Inflammatory diseases
10.2.6.Cardiovascular diseases
10.2.7.Haematological disorders
10.2.8.Neurological disorders
10.2.9.Dermatology
10.2.10.Others
10.3.  Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Observational trials
10.3.2.Interventional trials
10.3.3.Expanded access trials
10.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Clinical research organizations
10.4.2.Pharmaceutical and biotechnology companies
10.4.3.Research institutes
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Trial Phase Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Phase 0
11.1.2.Phase 1
11.1.3.Phase 2
11.1.4.Phase 3
11.1.5.Phase 4
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Infectious diseases
11.2.2.Cancer
11.2.3.Diabetes
11.2.4.Autoimmune disorders
11.2.5.Inflammatory diseases
11.2.6.Cardiovascular diseases
11.2.7.Haematological disorders
11.2.8.Neurological disorders
11.2.9.Dermatology
11.2.10.Others
11.3.  Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Observational trials
11.3.2.Interventional trials
11.3.3.Expanded access trials
11.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Clinical research organizations
11.4.2.Pharmaceutical and biotechnology companies
11.4.3.Research institutes
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Trial Phase Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Phase 0
12.1.2.Phase 1
12.1.3.Phase 2
12.1.4.Phase 3
12.1.5.Phase 4
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Infectious diseases
12.2.2.Cancer
12.2.3.Diabetes
12.2.4.Autoimmune disorders
12.2.5.Inflammatory diseases
12.2.6.Cardiovascular diseases
12.2.7.Haematological disorders
12.2.8.Neurological disorders
12.2.9.Dermatology
12.2.10.Others
12.3.  Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Observational trials
12.3.2.Interventional trials
12.3.3.Expanded access trials
12.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Clinical research organizations
12.4.2.Pharmaceutical and biotechnology companies
12.4.3.Research institutes
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Trial Phase Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Phase 0
13.1.2.Phase 1
13.1.3.Phase 2
13.1.4.Phase 3
13.1.5.Phase 4
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Infectious diseases
13.2.2.Cancer
13.2.3.Diabetes
13.2.4.Autoimmune disorders
13.2.5.Inflammatory diseases
13.2.6.Cardiovascular diseases
13.2.7.Haematological disorders
13.2.8.Neurological disorders
13.2.9.Dermatology
13.2.10.Others
13.3.  Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Observational trials
13.3.2.Interventional trials
13.3.3.Expanded access trials
13.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Clinical research organizations
13.4.2.Pharmaceutical and biotechnology companies
13.4.3.Research institutes
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Clinical Trials Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Trial Phase Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Phase 0
14.1.2.Phase 1
14.1.3.Phase 2
14.1.4.Phase 3
14.1.5.Phase 4
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Infectious diseases
14.2.2.Cancer
14.2.3.Diabetes
14.2.4.Autoimmune disorders
14.2.5.Inflammatory diseases
14.2.6.Cardiovascular diseases
14.2.7.Haematological disorders
14.2.8.Neurological disorders
14.2.9.Dermatology
14.2.10.Others
14.3.  Study Design Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Observational trials
14.3.2.Interventional trials
14.3.3.Expanded access trials
14.4.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Clinical research organizations
14.4.2.Pharmaceutical and biotechnology companies
14.4.3.Research institutes
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Charles River Laboratories International
15.2.2.Kendle International
15.2.3.Parexel International Corporation
15.2.4.Chiltern International Ltd
15.2.5.Omnicare Healthcare Co.
15.2.6.Audax Group
15.2.7.Laboratory Corporation of America Holdings
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Charles River Laboratories International
  • Kendle International
  • Parexel International Corporation
  • Chiltern International Ltd
  • Omnicare Healthcare Co.
  • Audax Group
  • Laboratory Corporation of America Holdings

Related Industry Reports

Clinical Waitlist Software Market

Global Preclinical Imaging Market

Global Clinical Nutrition Market

Clinical Research Services Market